$2.37 -0.02 (%) CTI BioPharma Corp -

Oct. 21, 2014 | 04:00 PM

Partner Headlines

  1. Morning Market Movers

    Benzinga | Sep. 17, 2014 | 09:38AM EST
  2. Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ...

    GuruFocus | Mar. 24, 2014 | 11:12AM EST
  3. After-Hours Movers: BV, SWHC, AVAV, CTIC Moving Higher, HCI, BOBE, CHEF, THOR Lower

    Benzinga | Mar. 4, 2014 | 17:24PM EST
  4. Earnings Scheduled For March 4, 2014

    Benzinga | Mar. 4, 2014 | 04:35AM EST
  5. Mornings Movers for Feb. 27, 2014: PEIX, JCP, SYMX, CIE, SHLD, BBY Higher, INO, NDLS, HK, CY, DYAX Lower

    Benzinga | Feb. 27, 2014 | 09:43AM EST
  6. This Week's Sector Gainers And Losers

    Benzinga | Feb. 13, 2014 | 11:38AM EST
  7. Morning Market Losers

    Benzinga | Jan. 27, 2014 | 10:33AM EST
  8. Cell Therapeutics to Reacquire Rights to Two Anti-Cancer Compounds from Novartis

    Benzinga | Jan. 13, 2014 | 06:01AM EST
  9. Cell Therapeutics Announces Removal of Partial Clinical Hold on Tosedostat

    Benzinga | Jan. 2, 2014 | 07:19AM EST
  10. Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement

    Benzinga | Dec. 18, 2013 | 05:56AM EST
  11. Cell Therapeutics Presents Interim Results from Phase 2 Tosedostat Trial in Older Patients with AML or MDS at ASH

    Benzinga | Dec. 10, 2013 | 06:07AM EST
  12. Cell Therapeutics Announces Results from Preclinical Study of Pixantrone at AACR-NCI-EORTC Conference

    Benzinga | Oct. 21, 2013 | 06:26AM EST
  13. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Oct. 7, 2013 | 07:11AM EST
  14. Cell Therapeutics Reaches Agreement with FDA on SPA for Planned Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis

    Benzinga | Oct. 7, 2013 | 05:56AM EST
  15. A Peek Into The Market Before The Trading Starts

    Benzinga | Dec. 10, 2012 | 00:21AM EST
  16. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts | Dec. 7, 2012 | 03:49AM EST
  17. Cell Therapeutics Says Study Achieved Endpoint Compared to Other Trials

    Benzinga | Dec. 5, 2012 | 11:04AM EST
  18. Cell Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 1, 2012 | 13:34PM EST
  19. Will Cell Therapeutics Stay Above New-Found Support?

    SchaeffersResearch | Oct. 12, 2012 | 10:15AM EST
  20. Bears Set the Bar Low for Cell Therapeutics

    SchaeffersResearch | Oct. 5, 2012 | 11:06AM EST
  21. Cell Therapeutics Prices Offering at $1.40/Common Share

    Benzinga | Oct. 5, 2012 | 01:33AM EST
  22. Stocks End Mixed as Spanish Concerns Linger with General Motors (GM) and Chipotle Mexican Grill (CMG) on the Move

    MarketIntelligenceCenter | Oct. 2, 2012 | 16:27PM EST
  23. Morning Market Movers

    Benzinga | Oct. 2, 2012 | 04:08AM EST
  24. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 10,000 Shares

    GuruFocus | Sep. 26, 2012 | 17:00PM EST
  25. Cell Therapeutics' Highly Selective Oral JAK 2 Inhibitor, Pacritinib, Demonstrates Encouraging Anti-tumor Activity

    Benzinga | Sep. 24, 2012 | 00:15AM EST
  26. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 40,000 Shares

    GuruFocus | Sep. 21, 2012 | 17:00PM EST
  27. Highs & Lows: Cell Therapeutics, Toll Brothers, Travelers, and Valero Energy

    SchaeffersResearch | Sep. 11, 2012 | 14:55PM EST
  28. Morning Market Movers

    Benzinga | Sep. 11, 2012 | 03:48AM EST
  29. Cell Therapeutics Says Holders Approve SBio Transaction

    Benzinga | Aug. 31, 2012 | 10:16AM EST
  30. Hertz Global Holdings, Zalicus Among Stocks Gapping Up Monday

    FoxBusiness | Aug. 27, 2012 | 04:30AM EST
  31. Ubiquiti Networks, Office Depot Among Stocks falling to Annual Lows Monday

    FoxBusiness | Aug. 13, 2012 | 10:32AM EST
  32. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 50,000 Shares

    GuruFocus | Aug. 10, 2012 | 15:19PM EST
  33. TreeHouse Foods, Alexco Resource Among Stocks hitting 52-Week Lows Thursday

    FoxBusiness | Aug. 9, 2012 | 06:32AM EST
  34. Cell Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 2, 2012 | 16:24PM EST
  35. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 50,000 Shares

    GuruFocus | Aug. 2, 2012 | 10:36AM EST
  36. Deckers Outdoor, Diamond Foods Among Stocks hitting 52-Week Lows Thursday

    FoxBusiness | Jun. 28, 2012 | 10:34AM EST
  37. Donaldson Company, Rovi Corporation Among Stocks falling to Annual Lows Friday

    FoxBusiness | Jun. 22, 2012 | 10:34AM EST
  38. Cell Therapeutics' Pixuvri Approved in European Union as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas

    Benzinga | May. 10, 2012 | 08:31AM EST
  39. European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri"

    Benzinga | Feb. 17, 2012 | 00:36AM EST
  40. These 4 Biotech Stocks Are a Buy Now

    GuruFocus | Feb. 8, 2012 | 11:16AM EST
  41. Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 10,000 Shares

    GuruFocus | Jan. 31, 2012 | 13:52PM EST
  42. Rodman & Renshaw Places Cell Therapeutics Under Review

    Benzinga | Jan. 30, 2012 | 07:22AM EST
  43. Morning Market Losers

    Benzinga | Jan. 30, 2012 | 03:08AM EST
  44. Cell Therapeutics Plummeting on NDA Withdrawl

    Benzinga | Jan. 30, 2012 | 02:52AM EST
  45. From Earlier: Cell Therapeutics Withdraws New Drug Application for Pixuvri and Plans to Resubmit in 2012

    Benzinga | Jan. 29, 2012 | 23:46PM EST
  46. Solar Stocks to watch in the week ahead

    Benzinga | Jan. 27, 2012 | 22:44PM EST
  47. From Earlier: Cell Therapeutic Announces FDA's Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012

    Benzinga | Jan. 3, 2012 | 00:16AM EST
  48. Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 10,000 Shares

    GuruFocus | Dec. 30, 2011 | 11:15AM EST
  49. Call Players Focus Some Attention on Cell Therapeutics

    SchaeffersResearch | Dec. 29, 2011 | 14:27PM EST
  50. Stocks To Watch For December 12

    Benzinga | Dec. 11, 2011 | 20:28PM EST
Trading Center